Skip to Main Content

Contact Us
Investors
Careers

Science Firsthand: Making the leap to intentionally designed degraders

How we orchestrate clinical trials to deliver hope for patients
Our science

Areas of focus

Science in action

Scientific resources & fact sheets

Technologies
Research & development

Clinical trials & research

Independent research

Patient safety

Pipeline
Product Development: Designing patient‑driven therapies for real life

Understanding behavioral symptoms in Alzheimer’s: Support for care partners
Medicines

All medicines

Medical information online

Help paying for your medicine

Investigational medicine access
Medical resources

Resources by therapeutic area

Disease state resources

Resources for healthcare providers
Building a healthier future together: Strengthening cancer care across Africa through partnership

Bringing life-saving medicines to more patients: Our commitment to low- and middle-income countries
Our impact

Patient advocacy

The Bristol Myers Squibb Foundation

Corporate giving

Economic responsibility

Social progress

Environmental sustainability

Population health
Life + science

All stories
Patients and purpose in action

Accelerating protein degradation science with AI and machine learning
Company news

All press releases

Media contacts
Investors

Stock information

Financial reporting

Analyst coverage

Events & presentations

Shareholder services

Investor contacts
Toni’s story

Bristol Myers Squibb employees from 33 nations pedal together, inspiring hope and advancing cancer research around the world
Our company

Leadership

Governance

Locations

Partnerships & business development

Working at BMS
Our commitments

Global inclusion

Transparency & reporting

Positions on key issues

Search

Search Jobs
Search U.S. Medical Information

Our science
Scientific media resources
CC Chemokine receptor 8 (CCR8) immune pathway fact sheet

Oncology
CC Chemokine receptor 8 (CCR8) immune pathway fact sheet

June 04, 2021

LinkedIn
X
Facebook
Email

Download CC Cchemokine receptor 8 (CCR8) immune pathway fact sheet

BMS

Subscribe to our stories

Beyond just relevant information about Bristol Myers Squibb's therapeutic areas and innovation, Our stories offer a window into the work our employees do every day for patients.

SUBSCRIBE

Navigation

Our science
Research & development
Medicines
Medical resources
Our impact
Life & science

Company news
Investors
Our company
Our commitments

Resources

Legal notice
Privacy notice center
Your privacy choices
Trademarks
Forward-looking statement
Modern slavery statement

Connect with us

Contact us
Our locations

© 2026 Bristol-Myers Squibb Company